|
|Section2= |Section6= |Section7= }} Fluralaner is a systemic insecticide and acaricide that is administered orally. The US Food and Drug Administration (FDA) approved the product Bravecto for flea treatment in dogs in May 2014. The EU approved the drug in February 2014.〔(【引用サイトリンク】title=MSD Animal Health receives EU approval for Bravecto )〕 ==Mode of action== Fluralaner inhibits γ-aminobutyric acid (GABA)-gated chloride channels (GABACls) and l-glutamate-gated chloride channels (GluCls). 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Fluralaner」の詳細全文を読む スポンサード リンク
|